Kyverna Therapeutics, Inc. (KYTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US5019761049
Kyverna Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -169.83 m USD |
| EBIT | -169.91 m USD |
| Net income | -161.31 m USD |
| Diluted EPS – continuing operations | -3.64 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
More stocks
- Ve Wong Corp (1203.TW)
- Guangdong Hongteo Accurate Technology Co Ltd (300176.SZ)
- Argo Global Listed Infrastructure Ltd (ALI.AX)
- Wuxi Xinan Technology Co. Ltd. A (301170.SZ)
- Seanergy Maritime Holdings Corp (SHIP)
- Shanghai DOBE Cultural & Creative Industry Development (Group) Co. LTD. (300947.SZ)
- PT Nusantara Sejahtera Raya Tbk (CNMA.JK)
- Eightco Holdings Inc. (ORBS)
- Shenzhen Wongtee International Enterprise Co Ltd (000056.SZ)
- KKR Real Estate Finance Trust Inc. (KREF)
- Putnam Premier Income Trust (PPT)
- S.P.I Landscape Design Co. Ltd. (300844.SZ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.